Monte Rosa Therapeutics

company

About

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.

  • 51 - 100

Details

Last Funding Type
Series A
Last Funding Money Raised
$32.50M
Industries
Biotechnology,Medical,Therapeutics
Founded date
Jan 1, 2018
Number Of Employee
51 - 100
Operating Status
Active

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways. Its rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$223.50M
Monte Rosa Therapeutics has raised a total of $223.50M in funding over 2 rounds. Their latest funding was raised on Mar 12, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 12, 2021 Series C $95M 1 Detail
Sep 24, 2020 Series B $96M 1 Detail
May 26, 2020 Series A $32.50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Monte Rosa Therapeutics is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Series C